- Skimmianine as a novel therapeutic agent suppresses proliferation and…
Number of the records: 1  

Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2

  1. LIU, Yang. Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2022, 2022, vol. 69, no. 3, s. 571-582.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.